|
FY2025
6 months to Dec 31, 2025
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Jan 1, 2022
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net (loss) income to cash provided by (used for) operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of deferred financing costs and debt (premium) discount, net | |||||
| Impairment of franchise rights acquired | |||||
| Impairment of intangible and long-lived assets | |||||
| Share-based compensation expense | |||||
| Deferred tax (benefit) provision | |||||
| Allowance for doubtful accounts | |||||
| Reserve for inventory obsolescence | |||||
| Foreign currency exchange rate loss (gain) | |||||
| Changes in cash due to: | |||||
| Receivables | |||||
| Inventories | |||||
| Prepaid expenses | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Deferred revenue | |||||
| Other long term assets and liabilities, net | |||||
| Income taxes | |||||
| Cash provided by (used for) operating activities | |||||
| Investing activities: | |||||
| Capital expenditures | |||||
| Capitalized software and website development expenditures | |||||
| Cash paid for acquisitions, net of cash acquired | |||||
| Other items, net | |||||
| Cash used for investing activities | |||||
| Financing activities: | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Proceeds from stock options exercised | |||||
| Cash paid for acquisitions | |||||
| Other items, net | |||||
| Cash provided by (used for) financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | |||||
| Net (decrease) increase in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash, beginning of period | |||||
| Cash and cash equivalents and restricted cash, end of period | |||||
Loading...
